8-K: Schwazze Reports Mixed Q1 2024 Results Amidst Competitive Market

Sentiment:

Quarterly Report


Schwazze announced a 4% increase in revenue for Q1 2024, but experienced a decrease in gross profit and adjusted EBITDA due to pricing pressures and increased operating expenses.

Worse than expectedThe company's gross profit margin decreased significantly year-over-year.The company reported a loss from operations compared to a profit in the same quarter last year.Adjusted EBITDA decreased significantly year-over-year.

Summary

  • Schwazze, operating as Medicine Man Technologies, reported a 4% increase in total revenue to $41.6 million for the first quarter of 2024, compared to $40.0 million in the same quarter last year.
  • The revenue increase was primarily driven by new store growth, but was partially offset by pricing pressures and increased competition in New Mexico.
  • Gross profit decreased to $17.9 million, or 43.1% of total revenue, compared to $21.8 million, or 54.6% of total revenue, in the first quarter of 2023, mainly due to pricing pressures in New Mexico and a higher mix of medical sales in Colorado.
  • Operating expenses increased to $20.6 million, compared to $16.2 million in the same quarter last year, due to personnel expenses and costs associated with 21 new stores.
  • The company reported a loss from operations of $2.7 million, compared to an income of $5.6 million in the same quarter last year.
  • Adjusted EBITDA decreased to $7.3 million, compared to $14.5 million in the first quarter of 2023, primarily due to lower gross margins and higher operating expenses.
  • Cash and cash equivalents decreased to $13.2 million as of March 31, 2024, compared to $19.2 million at the end of 2023.
  • Total debt increased to $159.7 million as of March 31, 2024, compared to $156.8 million at the end of 2023.

Sentiment

Score: 4

Explanation: The document presents mixed results with revenue growth offset by significant declines in profitability and cash flow. While there are some positive highlights, the overall tone is cautious due to the competitive market and financial challenges.

Positives

  • The company achieved a 4% increase in total revenue year-over-year.
  • Schwazze's sales in Colorado outperformed the market, increasing by 9% despite a 10% market decline.
  • Wholesale business showed quarter-over-quarter growth, reaching over 30% door penetration.
  • The company is seeing positive momentum from its pricing and promotional strategies.
  • The company is focused on driving operating efficiencies and optimizing assets by consolidating cultivation facilities and eliminating underperforming stores.

Negatives

  • Gross profit decreased to 43.1% of total revenue, down from 54.6% in the same quarter last year.
  • The company experienced a loss from operations of $2.7 million.
  • Adjusted EBITDA decreased to $7.3 million, down from $14.5 million in the same quarter last year.
  • Net loss was $16.1 million for the quarter, compared to a net income of $1.7 million in the same quarter last year.
  • Cash and cash equivalents decreased to $13.2 million from $19.2 million at the end of the previous quarter.
  • Total debt increased to $159.7 million from $156.8 million at the end of the previous quarter.

Risks

  • The Colorado market remains highly competitive with over 680 active recreational licenses.
  • New Mexico's cannabis market is experiencing a proliferation of new licenses, outpacing sales growth.
  • Pricing pressures in both Colorado and New Mexico are impacting gross margins.
  • The company is facing increased operating expenses due to new store openings.
  • The company's profitability is being impacted by the ramp-up of 21 new stores.
  • The company is exposed to regulatory risks and changes in cannabis laws.

Future Outlook

The company expects to continue driving improvements in customer acquisition, retention, and loyalty, and believes that its initiatives, coupled with its operating playbook and strict cost controls, will enable it to return to stronger levels of profitability moving forward.

Management Comments

  • We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico, said Forrest Hoffmaster, Interim CEO of Schwazze.
  • We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds.

Industry Context

The cannabis industry in Colorado and New Mexico is facing increased competition due to a high number of licenses, leading to pricing pressures and impacting profitability. Schwazze is focusing on improving customer experience and operational efficiencies to navigate these challenges.

Comparison to Industry Standards

  • Schwazze's revenue growth of 4% is below the average growth rate for some multi-state cannabis operators, which have seen growth rates in the double digits in some cases.
  • The decrease in gross margin to 43.1% is below the industry average for vertically integrated cannabis companies, which often aim for gross margins above 50%.
  • The decline in Adjusted EBITDA is a concern, as many cannabis companies are focusing on improving profitability and cash flow.
  • Companies like Curaleaf and Trulieve, which are larger multi-state operators, have reported higher gross margins and EBITDA margins, indicating that Schwazze has room for improvement in operational efficiency and pricing strategies.
  • The company's focus on consolidating cultivation facilities and eliminating underperforming stores is a common strategy in the industry to improve profitability, similar to actions taken by other cannabis companies facing competitive pressures.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in profitability and cash flow.
  • Employees may be impacted by the company's efforts to consolidate cultivation facilities and eliminate underperforming stores.
  • Customers may benefit from the company's focus on improving the in-store experience and expanding product assortment.
  • Suppliers may be affected by the company's efforts to optimize its supply chain.

Next Steps

  • The company will continue to focus on driving operating efficiencies and optimizing assets.
  • Schwazze will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.
  • The company will host a conference call to discuss the results.

Key Dates

DateDescription
2024-03-31End of the first quarter for which financial results are reported.
2024-05-15Date of the press release and conference call announcing Q1 2024 financial results.

Keywords

cannabis, retail, wholesale, Colorado, New Mexico, revenue, gross profit, EBITDA, dispensary, market share

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.